#United States #Life Sciences #Morrisville #Mercalis #Patient Support

Mercalis Reports Outstanding Performance in FY 2024

Mercalis Inc., a leader in life sciences commercialization, recently shared its impressive results from the 2024 fiscal year. The company has achieved significant milestones that emphasize its strategic vision and commitment to enhancing patient services across the biopharmaceutical value chain. CEO Scott Dulitz highlighted the company's growth trajectory, stating, "2024 was a tremendous year for Mercalis as we continued to crystallize our capabilities as a full-service life sciences commercialization platform."

Major Highlights from 2024

During the past fiscal year, Mercalis launched several innovative Patient Services programs targeting complex disease areas, including oncology and rare conditions. This initiative not only expanded the company's service offerings but also solidified its commitment to using cutting-edge technology to improve patient care.

Mercalis experienced over 20% revenue growth, largely driven by advancements in its Patient Support Services sector. By the end of the year, the company had formed partnerships with 19 of the top 20 global pharmaceutical firms, thereby cementing its reputation as a trusted partner within the industry.

Innovations and Investments

2024 was a year of innovation for Mercalis, particularly with enhancements made to its eServices portfolio. The introduction of electronic prior authorization (ePA) and automated follow-up capabilities facilitate improved communication within healthcare teams.

A groundbreaking addition to its offerings was the launch of the Mercalis eServices Curator, streamlining operational workflows by integrating various eServices, promoting efficiency, and reducing the effort required by users. Furthermore, the launch of the Connect for Life Sciences (CLS) Salesforce Health Cloud patient hub platform marked a significant milestone, providing first-class support tools to adapt to the evolving needs of patient support programs.

In its commitment to data security, Mercalis maintained ISO/IEC 27001 accreditation for its Information Security Management System (ISMS), a recognition affirming its robust data management strategies.

Expanded Service Offerings

To meet rising customer demand, Mercalis inaugurated a new state-of-the-art Non-Commercial Dispensing Pharmacy (NCDP), enhancing its dispensing capabilities by 300%. This facility underscores the company's dedication to optimizing the product journey for patients, especially for those who are uninsured or underinsured.

This new pharmacy complements its original NCDP, TC Script, launched in 2018, which has been facilitating patient assistance programs effectively. The pharmacy not only offers immediate therapy support but also ensures comprehensive capabilities for various dispensing processes.

Financial Achievements in Data and Insights

Another highlight of Mercalis's achievements in 2024 was the historical financial performance of its Data and Insights business segment. The synergy created by the merger of Triangle Insights and Policy Reporter led to acquiring nearly 100 new clients, showcasing the effectiveness of their market access solutions. With strategic partnerships enhancing its proprietary data platform, Mercalis continues to provide clients with real-time data insights and trends.

Looking Ahead

With a strong foundation and impressive results from 2024, Mercalis is poised for further growth into 2025. The company's strategies focus on continuously enhancing the patient experience and expanding its innovative solutions within the life sciences sector. By partnering with clients to navigate the complex healthcare landscape, Mercalis remains committed to accelerating value and improving patient lives.

Founded in 2000 and based in Morrisville, North Carolina, Mercalis has solidified itself as a go-to commercialization partner within the life sciences space. Its dedicated efforts have positively impacted millions of patients, making it a formidable force in the healthcare industry.

For more details on Mercalis and their offerings, visit www.mercalis.com.